MASTering systemic mastocytosis: Lessons learned from a large patient cohort

Area of Science:

• Hematology
• Rare Diseases
• Oncology

Background:

• Systemic mastocytosis (SM) is a rare condition often misdiagnosed due to nonspecific symptoms.
• Diagnostic challenges include nonspecific symptoms and reliance on invasive biopsies.

Purpose of the Study:

• To identify, classify, and characterize the natural history of patients diagnosed with Systemic Mastocytosis (SM).

Main Methods:

• Retrospective cohort study utilizing administrative data from a large managed care organization.
• Identification of confirmed SM cases based on World Health Organization criteria.
• Analysis of demographic data, diagnostic delays, disease progression, and healthcare resource utilization.

Main Results:

• Of 116 confirmed SM patients, 18% progressed from non-advanced to advanced disease over approximately 88 months.
• Average delay to diagnosis was over 58 months, with some patients initially misclassified or undiagnosed.
• SM patients exhibited increased healthcare utilization post-diagnosis compared to pre-diagnosis.

Conclusions:

• Increased understanding and awareness of rare diseases like SM are crucial for improving diagnostic accuracy.
• Prospective studies are needed to better characterize SM patients and identify optimal follow-up strategies for early detection of advanced disease.